Leadership

Disrupting the paradigm

As a woman-founded and led company with in-house manufacturing capabilities of its internally conceived portfolio of products, Femasys is well-positioned to deliver its solutions to the market with the achievement of global regulatory approvals.

Sue Owens

Vice President, Strategic Initiatives

Ms. Owens has over 20 years of successful leadership in medical sales with extensive experience introducing innovative products to the market for companies such as, Prelude DX, LifeCell (now Allergan/Abbvie), and Novadaq (now Stryker).  In her sales leadership positions, she has established an exemplary track record in team-building and clinical acumen in highly complex environments, demonstrating proficiency in new business development, strategic planning, and effective communication. Ms. Owens has spearheaded the successful launch of groundbreaking technologies in a variety of specialties, including women’s health, reshaping physician practices and streamlining workflows, while enhancing patient care and recovery. Ms. Owens holds a dual BA in Molecular, Cellular, Developmental Biology and Economics from the University of Colorado.